期刊文献+

胶质瘤中Axin和β-catenin表达及临床意义的研究 被引量:3

Study on clinical significance of expression of Axin and β-catenin in various grade of glioma
暂未订购
导出
摘要 目的探讨不同级别胶质瘤组织中轴蛋白(Axin)及β-连环素(β-catenin)的表达及其临床意义。方法制作82例不同级别胶质瘤的组织芯片,采用免疫组化SP法,检测芯片中Axin及β-catenin在不同级别胶质瘤中的表达。结果免疫组化检测显示Axin在低级别胶质瘤中表达(64.52%)较高级别胶质瘤(23.53%)高,差异有统计学意义(χ2=10.48,P<0.01),而β-catenin在低级别胶质瘤中表达(45.16%)较高级别胶质瘤低(80.30%),差异有统计学意义(χ2=13.61,P<0.01),Axin表达与β-catenin呈负相关(r=-0.035,P<0.05)。结论Axin、β-catenin可反映胶质瘤的恶性程度和病理分级,Axin在Wnt信号转导途径中起负调节作用。 Objective To investigate the clinical significance of expression of Axin and β- catenin in various grade of glioma. Methods Tissue microarrays were constructed in 82 cases of glioma. Two steps immunohistochemical staining was used to examine the expression of Axin and β-catenin in various grade of glioma. Results The positive expression rate of Axin in tow grade glioma(64.52% ) was much higher than that in high grade glioma(23.53% ) ( P 〈0. 01 ), while β-catenin showed lower expression in low grade glioma(45. 16% ) than in high grade glioma ( 80.30% ) ( P 〈 0. 01 ). These findings suggested that the expression of Axin was inversely correlated with that of β- catenin( r = - 0. 035, P 〈 0.05 ). Conclusion The expression of Axin and β- catenin indicates the malignant degree and grade of glioma. Axin acts as a negative regula- tor in Wnt signaling pathway.
出处 《临床和实验医学杂志》 2009年第6期24-25,28,共3页 Journal of Clinical and Experimental Medicine
关键词 胶质瘤 组织芯片 轴蛋白(Axin) β-连环素(β-catenin) Glioma Tissuemicroarray Axin β-catenin
  • 相关文献

参考文献1

  • 1E. Van Aken,O. De Wever,Correia A. da Rocha,M. Mareel. Defective E-cadherin/catenin complexes in human cancer[J] 2001,Virchows Archiv(6):725~751

同被引文献41

  • 1于晓敏,王辰,王军.Wnt信号通路的生物学效应及其与肺部疾病的关系[J].首都医科大学学报,2009,30(2):182-184. 被引量:16
  • 2环奕.WNT信号通路与肿瘤[J].基础医学与临床,2006,26(8):922-925. 被引量:18
  • 3朱玉德,季晓燕,黄强,张全斌,董军,王金鹏,王爱东,兰青.人脑胶质瘤干细胞初步研究[J].中华神经外科杂志,2007,23(2):127-130. 被引量:30
  • 4董伦,浦佩玉,王虎,王广秀,康春生,李彦和.EGFR反义RNA与p53基因联合转导抑制胶质瘤细胞增殖的体外实验研究[J].中华神经外科杂志,2007,23(9):678-681. 被引量:15
  • 5Thiepold AL,Lemercier S,Franz K,et al.Prophylactic Use of pegfilgrastim in patients treated with a nitrosourea and teniposide for recurrent clioma[J].Pharmacotherapy,2014,11 (10):1002-1409.
  • 6Johnson BE,Mazor T,Hong C,et al.Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma[J].Science,2014,343 (6167):189-193.
  • 7Kailiang Zhang,Junxia Zhang,Lei Han,et al.Wnt/beta-catenin signaling in glioma[J].Neuroimmune Pharmacol,2012,7 (4):740-749.
  • 8Wu W,Tian Y,Wan H,et al.The expressions of Wnt/β-catenin pathway-related components in brainstem gliomas[J].Can J Neurol Sci,2013,40 (3):355-360.
  • 9Galiatsatos P,Foulkers W.Fammilial adenomatous polyposis[J].Am J Gastroenterol,2006,101:385-398.
  • 10Jmswal AS,Balusu R,Narayan S.Involvement of adenomatous polyposis coli in colorectal tumorigenesis[J].Front Biosci,2005,10:1118-1134.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部